SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-012333
Filing Date
2024-04-01
Accepted
2024-04-01 16:00:54
Documents
69
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1531900
2 ex4-1.htm EX-4.1 38711
3 ex21-1.htm EX-21.1 3428
4 ex31-1.htm EX-31.1 20331
5 ex31-2.htm EX-31.2 20456
6 ex97.htm EX-97.1 32111
7 ex99-1.htm EX-99.1 40876
8 ex99-2.htm EX-99.2 36113
9 ex99-3.htm EX-99.3 18330
10 form10-k_001.jpg GRAPHIC 22820
11 form10-k_002.jpg GRAPHIC 12061
12 form10-k_003.jpg GRAPHIC 20362
13 form10-k_004.jpg GRAPHIC 17245
  Complete submission text file 0001493152-24-012333.txt   5776579

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE ptix-20231231.xsd EX-101.SCH 34612
15 XBRL CALCULATION FILE ptix-20231231_cal.xml EX-101.CAL 46708
16 XBRL DEFINITION FILE ptix-20231231_def.xml EX-101.DEF 180874
17 XBRL LABEL FILE ptix-20231231_lab.xml EX-101.LAB 355513
18 XBRL PRESENTATION FILE ptix-20231231_pre.xml EX-101.PRE 278875
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 580870
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12555 | Film No.: 24808987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)